Europe Vaccine Administration Devices Market, By Product (Syringes, Auto Injectors, Jet Injectors, Micro Needles, Inhalation/Pulmonary Delivery, Microinjection System, Pen Injector Devices, Biodegradable Implants, Electroporation-Based Needle Free Injection Systems, Buccal /Sublingual Vaccine Delivery Systems, Auto-Injector Trainer Devices and Others Devices), Route of Administration (Intramuscular, Subcutaneous, Intradermal), Type (Marketed Vaccines and Clinical-Stage Vaccines (Electroporation)), Brand (BD Accuspray Nasal Spray System, BD Hypak for Vaccines Glass Pre-Fillable Syringe System, BD Uniject Auto-Disable Pre-Fillable Injection System, Gx InnoSafe, Gx RTF ClearJect, Plajex, Others), Dosage (Fixed and Variable), Vaccine Type (Bivalent Oral PolioVaccine, BCG Vaccine, Tetanus-Diphtheria Vaccine, DTP-HEPB-HIB Vaccine, Influenza Vaccine, Pneumococcal Conjugate Vaccine, Measles Vaccine, Others), Modality (Automatic Vaccine Administration Device and Manual Vaccine Administration Device), Usability (Disposable and Reusable), End User (Hospitals, Community Centers, Homecare Setting, Research and Academic Institutes, Ambulatory Surgical Center, Others), Distribution Channel (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2030.
Europe Vaccine administration devices Market Analysis and Size
Diabetic patients are becoming more prevalent over the world. The global demand for COVID-19 vaccine offers a substantial opportunity for growth, greatly helping the industry. Growing research and investment in the development of vaccines is also one of the main drivers of the market. The urgency to locate and oversee a COVID-19 vaccine has caused interest in offering an effective and safe viral delivery system, or preferably, multiple delivery systems.
Data Bridge Market Research analyses a growth rate in the vaccine administration devices market in the forecast period 2023-2030. The expected CAGR of vaccine administration devices market is tend to be around 8% in the mentioned forecast period. The market is valued at USD 926.68 million in 2022, and it would grow upto USD 1715.22 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Europe Vaccine administration devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Syringes, Auto Injectors, Jet Injectors, Micro Needles, Inhalation/Pulmonary Delivery, Microinjection System, Pen Injector Devices, Biodegradable Implants, Electroporation-Based Needle Free Injection Systems, Buccal /Sublingual Vaccine Delivery Systems, Auto-Injector Trainer Devices and Others Devices), Route of Administration (Intramuscular, Subcutaneous, Intradermal), Type (Marketed Vaccines and Clinical-Stage Vaccines (Electroporation)), Brand (BD Accuspray Nasal Spray System, BD Hypak for Vaccines Glass Pre-Fillable Syringe System, BD Uniject Auto-Disable Pre-Fillable Injection System, Gx InnoSafe, Gx RTF ClearJect, Plajex, Others), Dosage (Fixed and Variable), Vaccine Type (Bivalent Oral PolioVaccine, BCG Vaccine, Tetanus-Diphtheria Vaccine, DTP-HEPB-HIB Vaccine, Influenza Vaccine, Pneumococcal Conjugate Vaccine, Measles Vaccine, Others), Modality (Automatic Vaccine Administration Device and Manual Vaccine Administration Device), Usability (Disposable and Reusable), End User (Hospitals, Community Centers, Homecare Setting, Research and Academic Institutes, Ambulatory Surgical Center, Others), Distribution Channel (Direct Tender, Retail Sales)
|
|
Countries Covered
|
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe
|
|
Market Players Covered
|
B.D. (U.S.), INOVIO Pharmaceuticals (U.S.), Vaxxas (U.S.), Gerresheimer AG (Germany), Corium Inc. (U.S.), Enesi (U.S.), Micropoint Technologies (Singapore), SCHOTT AG (Germany), 3M (U.S.), Mystic Pharmaceuticals (U.S.), NanoPass Rev (U.S.), Terumo Europe NV (Belgium), D'Antonio Consultants International, Inc. (U.S.), West Pharmaceutical Services, Inc. (U.S.)., Mylan N.V. (U.S.), Medical International Technologies Inc. (Canada), Antares Pharma (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Vaccine administration is the type of process that helps in the insertion of the vaccines through different modes of administration which will help in the prevention of the associated disease. Vaccines are as a set of biological preparations that combat humans from viruses and bacteria-related infections. Some of the vaccine kinds are inactivated/killed vaccinations, live/attenuated vaccines, toxoid vaccines, and conjugate vaccines. Using a syringe or needle, vaccines are administered intramuscularly or subcutaneously.
Europe Vaccine administration devices Market Dynamics
Drivers
- Increasing Strategic Developments by Market Players
Different market players are engaged in strategic activities such as mergers and acquisitions to increase the availability of products in the market. For instance, the next-generation glass pre-fillable syringe (PFS) named BD Effivax was launched by Becton, Dickin, son, and Company in 2022. The Company sets a new standard for performance for vaccine PFS with new criteria for cosmetics, contamination, processability, and integrity. Thus, this factor increases the growth of the market.
- Increasing R&D Activities
Growing research and investment in the development of vaccines is also one of the major drivers of the market. The Canadian Institutes of Health Research Institute of Infection and Immunity supports and funds research activities aimed at decreasing the burden of allergies, infectious diseases, and immune-mediated diseases. The institute invests about USD 1 million every year to support the research of hepatitis C, USD 45.7 million through partnerships for pandemic influenza research, and USD 22.5 million to support the CIHR HIV/AIDS Research Initiative. Thus, this boosts the market growth.
Opportunities
- Growing Demand of Auto-Disable (AD) Syringes
The increasing demand of auto-disable (AD) syringes boost the demand of the market. WHO recommends the usage of auto-disable (AD) syringes for the immunization program as they are made to prevent re-use as AD syringes lock automatically after a single use. Additionally, AD syringes provide the assurance that vaccinations are administered safely and without chances of contamination. Thus, this factor boost the growth of the market.
- Increasing Rate of Product Launches
There are increasing number of product launches associated with vaccines that are helpful in surging the market growth. For instance, vaccines developed by the Serum Institute of India acquired a 50% share in a pharma packing firm, Schott Kaisha in 2021. This initiative positions the Serum Institute of India in a joint venture with Schott AG which is a specialty glass company based in Germany. Moreover, numerous initiatives taken by government agencies to develop new vaccines offer opportunities for growth in the market. Thus, this factor increases the market growth.
Restraints/Challenges
- Complications Associated with Vaccine Administration Devices
There are various complications associated with vaccine administration devices that impede the market growth. Effects such as fussiness, loss of appetite, fever, feeling tired, and vomiting. There are more serious reactions, such as consistent crying for 3 hours or more, seizures, high fever (over 105°F) after DTaP vaccination. These all factors hamper the growth of the market.
This vaccine administration devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vaccine administration devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2020, Enesi Pharma has been shortlisted for its best vaccine platform IMPLAVAX solid dose vaccine administration platform. This technology provides needle free vaccine delivery, which overcomes the fear of patients towards needle stick injuries. This award and recognition assisted the company to get recognized for its vaccine administration technology.
- In 2019, Gerresheimer AG launched a new glass innovation and technology centre in the U.S. As the company is engaged in manufacturing of glass syringes and needles for vaccine administration. This expansion assisted the company to improve the production of various vaccine administration devices.
Europe Vaccine administration devices Market Scope
The vaccine administration devices market is segmented on the basis of product, route of administration, type, brand, dosage, vaccine type, modality, usability, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Syringes
- Auto Injectors
- Jet Injectors
- Micro Needles
- Inhalation/Pulmonary Delivery
- Microinjection System
- Pen Injector Devices
- Biodegradable Implants
- Electroporation-Based Needle Free Injection Systems
- Buccal /Sublingual Vaccine Delivery Systems
- Auto-Injector Trainer Devices
- Others Devices
Route of Administration
- Intramuscular
- Subcutaneous
- Intradermal
Type
- Marketed Vaccines
- Clinical-Stage Vaccines (Electroporation)
Brand
- BD Accuspray Nasal Spray System
- BD Hypak for Vaccines Glass Pre-Fillable Syringe System
- BD Uniject Auto-Disable Pre-Fillable Injection System
- Gx InnoSafe
- Gx RTF ClearJect, Plajex
- Others
Dosage
- Fixed
- Variable
Vaccine Type
- Bivalent Oral PolioVaccine
- BCG Vaccine
- Tetanus-Diphtheria Vaccine
- DTP-HEPB-HIB Vaccine
- Influenza Vaccine
- Pneumococcal Conjugate Vaccine
- Measles Vaccine
- Others
Modality
- Automatic Vaccine Administration Device
- Manual Vaccine Administration Device
Usability
- Disposable
- Reusable
End User
- Hospitals
- Community Centers
- Homecare Setting
- Research and Academic Institutes
- Ambulatory Surgical Center
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Vaccine administration devices Market Regional Analysis/Insights
The vaccine administration devices market is analyzed and market size insights and trends are provided by product, route of administration, type, brand, dosage, vaccine type, modality, usability, end user, and distribution channel as referenced above.
The major countries covered in the vaccine administration devices market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
Germany is anticipated to grow with the highest CAGR in the forecast period due to growing demand of vaccine administration devices for fixed vaccine administration devices segment. Also, several governments globally are growing their spending on vaccination and demonstrating strong and effective leadership and ownership of immunization programs in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe Vaccine administration devices Market Share Analysis
The vaccine administration devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to vaccine administration devices market
Key players operating in the vaccine administration devices market include:
- Medtronic (Ireland)
- Stening SRL (Argentina)
- Cook (U.S.)
- Bicakcilar Medical (Istanbul)
- TROGE MEDICAL GmbH (Germany)
- Henan Tuoren Medical Device Co., Ltd. (China)
- Fisher & Paykel Healthcare Limited (new Zealand)
- Medis Medical (UK) Ltd (U.K.)
- Pulmodyne, Inc. (U.S.)
- Fuji Systems (Japan)
- DEAS S.R.L. (Italy)
- Sterimed Group (India)
- ConvaTec Group PLC (U.K.)
- Smiths Medical (U.K.)
- Andreas Fahl Medizintechnik – Vertrieb GmbH (Germany)
- Boston Medical Products Inc. (U.S.)
- TRACOE medical GmbH (Germany)
- Teleflex Incorporated (U.S.)
- Well Lead Medical Co., Ltd (China)
SKU-